Physician profile
Eric T Behm
NPI 1437538865
$2,777.69
in general payments reported to CMS, 2019-2025
16 companies · $620 in 2025
The $620 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.52 · 2022: $219 · 2023: $768 · 2024: $1,124 · 2025: $620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,512.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,637.41 | 2022-2025 | Apretude, Cabenuva, Dovato |
| Gilead Sciences, INC. | $532.11 | 2022-2025 | Descovy |
| Abbvie INC. | $155.81 | 2023-2025 | |
| Organon LLC | $80.77 | 2023 | Nexplanon |
| Antares Pharma, INC. | $73.53 | 2021-2025 | Xyosted |
| Medtronic, INC. | $65.34 | 2024 | Intellis Adaptivestim |
| Novo Nordisk INC | $41.89 | 2024 | Rybelsus, Ozempic, Wegovy |
| Exact Sciences Corporation | $32.20 | 2025 | The Cologuard Plus Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $30.95 | 2021-2024 | Trintellix |
| Astrazeneca Pharmaceuticals LP | $28.79 | 2024 | Airsupra, Farxiga |
| Lilly USA, LLC | $19.34 | 2024 | Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $19.10 | 2023 | Delstrigo, Pifeltro |
| Abbott Laboratories | $16.65 | 2023 | Proclaim |
| Hologic Sales and Service, LLC | $16.60 | 2022 | |
| Acerus Pharmaceuticals Corporation | $14.05 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $13.15 | 2024 | Zio Xt Patch, Zio Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Behm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.